Status:
ACTIVE_NOT_RECRUITING
Early Diagnosis of Atrial Fibrillation in the Wait-Time Prior to Seeing a Cardiologist
Lead Sponsor:
Victoria Cardiac Arrhythmia Trials
Conditions:
Atrial Fibrillation
Atrial Fibrillation Paroxysmal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A randomized patient-oriented trial to investigate whether continual symptomatic use of the Kardia Mobile monitoring device is a superior strategy for diagnosing Atrial Fibrillation (AF) in comparison...
Detailed Description
Wait-times from referral by a family practitioner to seeing a specialist have increased greatly over the past 10 years in Canada. The Fraser institute reports an 11 week wait-time in BC in 20161. Our ...
Eligibility Criteria
Inclusion
- Age \>18
- Referral for episodic symptoms that may be due to arrhythmia (e.g. palpitations, dyspnea, or pre-syncope)
- At least one risk factor from CHADS-65 CCS Algorithm
Exclusion
- Previous diagnosis of atrial fibrillation
- Already anticoagulated for another diagnosis (e.g. metallic heart valve or pulmonary embolism)
- Symptoms typical of non-arrhythmic cause (e.g. exertional chest pain)
Key Trial Info
Start Date :
December 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2024
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04302311
Start Date
December 18 2018
End Date
March 1 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Cardiac Arrhythmia Trials
Victoria, British Columbia, Canada, V8Z 0B9